Shares of Hepatitis C treatment providers Inhibitex (INHX) and Vertex Pharmaceuticals (VRTX)...

|By:, SA News Editor

Shares of Hepatitis C treatment providers Inhibitex (INHX) and Vertex Pharmaceuticals (VRTX) show upward momentum following the news of Gilead's (GILD) blockbuster deal to buy Pharmasset (VRUS). Premarket: INHX +31%, VRTX +2%.